SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001626199-22-000045
Filing Date
2022-05-12
Accepted
2022-05-12 16:25:41
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alpn-20220331.htm   iXBRL 10-Q 1847756
2 EX-31.1 alpn-ex311_20220331.htm EX-31.1 9050
3 EX-31.2 alpn-ex312_20220331.htm EX-31.2 9025
4 EX-32.1 alpn-ex321_20220331.htm EX-32.1 6168
5 EX-32.2 alpn-ex322_20220331.htm EX-32.2 6374
  Complete submission text file 0001626199-22-000045.txt   5655261

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20220331.xsd EX-101.SCH 35520
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alpn-20220331_cal.xml EX-101.CAL 52871
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alpn-20220331_def.xml EX-101.DEF 133886
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20220331_lab.xml EX-101.LAB 442945
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20220331_pre.xml EX-101.PRE 264767
54 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20220331_htm.xml XML 666192
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 22918226
SIC: 2834 Pharmaceutical Preparations